n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Acute Myelogenous Leukemia in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanishi, Y | 1 |
| Kamijo, R | 1 |
| Takizawa, K | 1 |
| Hatori, M | 1 |
| Nagumo, M | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines.
Topics: Antineoplastic Agents; Blotting, Western; Butanones; Cell Division; Cell Transformation, Neoplastic; | 2001 |